Quick answer: A cosmetic sold in the United States needs truthful, non-misleading labeling that matches its product category and intended use. For a retail cosmetic, that commonly includes an identity statement, net quantity, business name and address, ingredient declaration, and any required warning. Claims need review before artwork is printed because they can change the product’s legal category.
Last reviewed: September 15, 2026
Regulatory authority: U.S. Food and Drug Administration (FDA)
What are U.S. cosmetic labeling requirements?
FDA states that cosmetics marketed in the United States, whether imported or made domestically, must comply with the Federal Food, Drug, and Cosmetic Act, the Fair Packaging and Labeling Act, and applicable FDA regulations. The practical requirements depend on the exact product, its package, its intended use and its claims. A reusable label template can help a brand work efficiently, but it does not replace a product-specific review.
| Label element | Purpose | Typical placement |
|---|---|---|
| Identity statement | Identifies the product or use | Principal display panel |
| Net quantity | Accurately states package contents | Principal display panel |
| Business statement | Names the manufacturer, packer or distributor | Information panel |
| Ingredients | Declares ingredients for covered retail cosmetics | Information panel |
| Warnings and directions | Addresses hazards or prescribed cautions | Conspicuous panel |
First, confirm that the product is a cosmetic
In U.S. law, intended use matters. A product that cleanses, beautifies, promotes attractiveness or alters appearance may be a cosmetic. However, language that promises to treat or prevent disease, or affect the structure or function of the body, can make a product a drug or a combination cosmetic/drug. Ordinary cosmetic products are not FDA-approved before sale, and an FDA registration or product listing is not product approval.
| Claims review question | Reason to check |
|---|---|
| Does the claim say it treats, cures or prevents a condition? | It may be a drug claim. |
| Does it describe appearance only? | Cosmetic claims still must be truthful and non-misleading. |
| Does the product use a color additive? | Color additives have specific permitted-use and certification rules. |
| Could normal misuse create a hazard? | A warning or directions for safe use may be required. |
Principal display panel: identity and net quantity
The principal display panel is the portion of a label most likely to be shown or examined when a consumer buys the product. FDA’s labeling materials describe the identity statement and net quantity declaration, together with prominence and conspicuousness principles. Required information must be readable under customary conditions of purchase; decorative graphics, poor contrast and overly small type should not obscure it.
For a brand team, connect final artwork to the approved fill specification. The front-panel quantity should be checked again whenever a size, tube, jar, carton or fill volume changes.
Name and place of business
The label can identify the manufacturer, packer or distributor. Where the named company is not the manufacturer, qualifying wording such as “Manufactured for” or “Distributed by” may be appropriate. The commercial role and address on the final label should be agreed in writing between the brand owner, importer and manufacturer.
Ingredient declaration
FDA explains that cosmetics customarily sold at retail to consumers generally require an ingredient declaration under 21 CFR 701.3. The usual approach is a declaration in descending order of predominance, subject to regulatory exceptions such as ingredients at one percent or less and color additives. The formula worksheet used in a factory is not automatically a consumer-ready ingredient declaration; names, order and placement need a final label review.
| Pre-print checkpoint | What to verify |
|---|---|
| Formula version | The approved formula and intended U.S. market |
| Ingredient list | Names, order and presentation against applicable rules |
| Package format | Whether available surface area affects permitted label placement |
| Warnings | Product-specific risks and prescribed statements |
| Claims | Marketing language matches the selected regulatory route |
Warnings, English and readability
Required U.S. label statements must be in English and must be prominent and conspicuous. Where a cosmetic may be hazardous when misused, appropriate warnings and adequate directions for safe use are required. Some product categories have prescribed cautions. A good artwork review checks contrast, placement, spacing, letter size and whether required text remains visible after label curvature, seams or package decoration are considered.
What the manufacturer provides—and what the brand owner owns
| Manufacturer can provide | Brand owner should approve |
|---|---|
| Formula/INCI information, batch records, COA, manufacturing documents and packaging-compatibility information | Target market, named label entity, final claims and final artwork |
| Stability or microbiological information where appropriate | Commercial positioning, retail presentation and importer coordination |
| Technical review of fill and packaging fit | That the final label matches the actual product placed on the market |
Neither party should assume a claim is approved because a sample or an artwork file was shared. Keep dated approvals for formula, label, claims, packaging and supplier documentation.
Common mistakes
- Copying a label from another market without adapting it for the United States.
- Using disease-treatment or body-function claims on a product sold as a cosmetic.
- Leaving quantity, ingredients or business wording until the last design round.
- Using low-contrast or unreadably small required text.
- Confusing FDA listing or facility registration with FDA approval.
Pre-launch checklist
- Confirm product classification and intended claims.
- Review identity, quantity, business statement and ingredients against final packaging.
- Check warnings, color additives and special-category requirements where relevant.
- Retain source documents, artwork approvals and batch-level records.
- Seek qualified regulatory review for high-risk claims before launch.
How MOOYAM supports label-ready manufacturing
MOOYAM provides cosmetic OEM/ODM manufacturing and technical documentation support for international beauty brands. We can help organize formula information, INCI details, COA, manufacturing documentation, stability information, microbiological reports, packaging-compatibility information and batch records for the brand’s review. Explore our manufacturing capabilities, export manufacturing support, private label makeup solutions, or contact MOOYAM with your product brief.
FAQ
Does FDA approve cosmetic labels before sale?
No. FDA does not pre-approve ordinary cosmetic labeling before market entry; the label must still comply with applicable law.
Must imported cosmetics follow the same labeling rules?
Yes. FDA says imported cosmetics must meet the same U.S. laws and regulations as domestically produced cosmetics.
Do retail cosmetics need an ingredient list?
They generally do, subject to limited regulatory exceptions and special presentation rules.
Can a cosmetic say it treats acne or eczema?
That wording can create a drug claim. Evaluate the intended use and drug requirements before using it.
Does a registration number prove FDA approval?
No. Facility registration or product listing is not FDA approval of an ordinary cosmetic product.
Official sources
- FDA Cosmetic Labeling Guide
- FDA Summary of Cosmetics Labeling Requirements
- FDA Cosmetics Labeling Claims
- FDA resources for 21 CFR Part 701
Regulatory requirements may change. Brands should verify current requirements with the relevant regulatory authority or qualified compliance professional before placing cosmetic products on the market.